Chrysa Mineo

Angel

Overview

Gender
female
Investor Type
Angel

Ms. Mineo has served as our Vice President, Corporate Development since July 2009 and is responsible for our collaborations with AbbVie, Ono and Lilly and our partnership with Janssen Pharmaceuticals.

Ms. Mineo has 23 years of experience in the biotechnology industry, including in roles of increasing responsibility from 1997 to 2009, leading to Senior Director of Business Development for Neurocrine Biosciences.

Prior to Neurocrine, Ms. Mineo served in various capacities in research, marketing and business development for such companies as Amgen, DNAX Research Institute, Schering Plough and Baxter Biotech.

She began her career in 1987 with Amgen as a member of a cellular biology team.

Ms. Mineo holds a B.S. in Zoology from the University of California, Davis and received her M.B.A. from Duke University's Fuqua School of Business.

Personal Investments

Number of Investments
1
Chrysa Mineo has made 1 investments. Their most recent investment was on May 1, 2020, when Alume Biosciences raised $5.50M.
Date Company Name Round Money Raised Industry
May 1, 2020 Alume Biosciences Series A $5.50M Biotechnology Detail